by Richard Daverman, PhD
February 20, 2013 -- China’s SFDA has announced a set of newly-revised regulations for the country’s drug distributors. These new Good Supply Practices (GSP) for drugs, which comprise 187 articles, will promote higher standards of protection for the country’s drug supply among wholesalers and retailers. An SFDA spokesperson also said the government wants to reduce the number of China’s drug wholesalers from a current 13,000 to just 3,000, a draconian rollup of the country’s highly fragmented distribution system. More details....
